Researchers at The University of Texas MD Anderson Cancer Center have identified a targetable driver of brain metastases in ...

Low-dose aspirin may limit cancer metastasis by inhibiting platelet activation and enhancing T-cell immunity, supporting biomarker guided use while balancing bleeding risk overall.

Here is shown that standard chemotherapy with 5-FU and oxaliplatin induces a long-lasting, metastasis-resistant state by durably reshaping the gut microbiota. This remodeling increases production of ...

Chemotherapy reshapes gut bacteria in ways that send powerful signals throughout the body. These signals reprogram immune ...

A new nano-sized drug carrier that finds bone tumors and releases treatment exactly where it's needed is here to improve the ...

Background and objectives Bone marrow metastasis (BMM) from non-hematolymphoid malignancies with resultant cytopenia(s) can mimic primary hematolymphoid disorders. This study aimed to investigate the ...

Chemotherapy’s gut damage turns out to have a surprising upside. By changing nutrient availability in the intestine, it ...

Images below confirm clinical responses seen in patients with metastatic orbital (eye), temporal (brain), liver, and spine ...

Bria-IMT demonstrates a median overall survival of 15.6 months, surpassing historical data for heavily pretreated metastatic ...

While there has been remarkable progress in the number of people surviving with stage 4 cancer, MSK remains dedicated to research that will spur much needed advances.

Millions of people worldwide are diagnosed with cancer every year. In advanced tumor diseases, cancer cells detach from the ...

Why do some tumors spread while others remain localized? The mechanisms governing the metastatic potential of tumor cells ...